HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter N Morcos Selected Research

danoprevir

5/2016Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis.
5/2015Characterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir.
11/2013A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail.
9/2013Pharmacokinetics of a three-way drug interaction between danoprevir, ritonavir and the organic anion transporting polypeptide (OATP) inhibitor ciclosporin.
10/2010Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter N Morcos Research Topics

Disease

19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2014
7Neoplasms (Cancer)
01/2022 - 07/2017
5Chronic Hepatitis C
05/2016 - 10/2010
3Disease Progression
01/2022 - 01/2017
3Hematologic Neoplasms (Hematological Malignancy)
11/2021 - 01/2019
3Infections
01/2015 - 10/2010
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 01/2019
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2019
2Neoplasm Metastasis (Metastasis)
03/2016 - 09/2014
2Human Influenza (Influenza)
04/2015 - 09/2012
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Body Weight (Weight, Body)
12/2018
1Central Nervous System Diseases (CNS Diseases)
01/2017
1Fibrosis (Cirrhosis)
05/2016
1Breast Neoplasms (Breast Cancer)
05/2015
1Lung Neoplasms (Lung Cancer)
05/2015
1Chronic Kidney Failure (Chronic Renal Failure)
04/2015
1Anuria
04/2015
1Pericardial Effusion
09/2014
1Pleural Effusion (Pleural Effusions)
09/2014
1Neutropenia
09/2014
1Headache (Headaches)
09/2014
1Fatigue
09/2014
1Brain Neoplasms (Brain Tumor)
09/2014
1Acute Kidney Injury (Acute Renal Failure)
09/2014
1Myalgia
09/2014
1Rheumatoid Arthritis
03/2013
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2013

Drug/Important Bio-Agent (IBA)

20alectinibIBA
01/2022 - 09/2014
14Anaplastic Lymphoma KinaseIBA
11/2021 - 03/2016
11CrizotinibIBA
01/2022 - 09/2014
5danoprevirIBA
05/2016 - 10/2010
3Antiviral Agents (Antivirals)IBA
05/2016 - 10/2010
3Ritonavir (Norvir)FDA Link
05/2016 - 09/2013
2Rituximab (Mabthera)FDA Link
11/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
12/2019 - 05/2015
2Pharmaceutical PreparationsIBA
01/2019 - 11/2013
2Oseltamivir (Tamiflu)FDA Link
04/2015 - 09/2012
1Biomarkers (Surrogate Marker)IBA
01/2022
1Cell-Free Nucleic AcidsIBA
01/2022
1vasectrin I (VS I)IBA
11/2021
1glofitamabIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2020
1cibisatamabIBA
12/2019
1Neoplasm Antigens (Tumor Antigens)IBA
12/2019
1Bispecific AntibodiesIBA
12/2019
1Granzymes (Granzyme)IBA
12/2019
1Blood Proteins (Serum Proteins)IBA
07/2017
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2015
1Carrier Proteins (Binding Protein)IBA
05/2015
1AnionsIBA
05/2015
1Peptides (Polypeptides)IBA
05/2015
1Ribavirin (Virazole)FDA LinkGeneric
01/2015
1peginterferon alfa-2a (Pegasys)FDA Link
01/2015
1Cytochrome P-450 CYP2C9IBA
11/2013
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2013
1Peptide Hydrolases (Proteases)FDA Link
09/2013
1Monoclonal AntibodiesIBA
03/2013
1tocilizumab (atlizumab)FDA Link
03/2013
1Neuraminidase (Sialidase)IBA
09/2012
12'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidineIBA
10/2010
1Protease Inhibitors (Protease Inhibitor)IBA
10/2010
1NucleosidesIBA
10/2010
1InterferonsIBA
10/2010

Therapy/Procedure

3Therapeutics
12/2019 - 10/2010
1Immunotherapy
12/2019
1Duration of Therapy
01/2018
1Drug Therapy (Chemotherapy)
03/2016
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
04/2015
1Peritoneal Dialysis
04/2015